Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/212835
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Prediction of esophageal varices by liver stiffness and platelets in persons with HIV infection and compensated advanced chronic liver disease |
Autor: | Merchante, Nicolás CSIC ORCID; Saroli Palumbo, Chiara; Mazzola, Giovanni; Pineda, Juan A. CSIC ORCID; Téllez, Francisco; Rivero-Juárez, Antonio; Ríos-Villegas, María José; Maurice, James B.; Westbrook, Rachel H.; Judge, Rebekah; Guaraldi, Giovanni; Schepis, Filippo; Perazzo, Hugo; Rockstroh, Juergen; Boesecke, Christoph; Klein, Marina B.; Cervo, Adriana; Ghali, Peter; Wong, Philip; Petta, Salvatore; Ledinghen, Victor de; Macías Sánchez, Juan CSIC ORCID; Sebastiani, Giada | Palabras clave: | Esophagogastroduodenoscopy Transient elastography Baveno VI criteria HCV coinfection Variceal bleeding |
Fecha de publicación: | 2019 | Editor: | Oxford University Press | Citación: | Clinical Infectious Diseases: (2019) | Resumen: | [Background] People living with human immunodeficiency virus (PLWH) are at increased risk of cirrhosis and esophageal varices. Baveno VI criteria, based on liver stiffness measurement (LSM) and platelet count, have been proposed to avoid unnecessary esophagogastroduodenoscopy (EGD) screening for esophageal varices needing treatment (EVNT). This approach has not been validated in PLWH. [Methods] PLWH from 8 prospective cohorts were included if they fulfilled the following criteria: (1) compensated advanced chronic liver disease (LSM >10 kPa); (2) availability of EGD within 6 months of reliable LSM. Baveno VI (LSM <20 kPa and platelets >150 000/μL), expanded Baveno VI (LSM <25 kPa and platelets >110 000/μL), and Estudio de las Hepatitis Víricas (HEPAVIR) criteria (LSM <21 kPa) were applied to identify patients not requiring EGD screening. Criteria optimization was based on the percentage of EGDs spared, while keeping the risk of missing EVNT <5%. [Results] Five hundred seven PLWH were divided into a training (n = 318) and a validation set (n = 189). EVNT were found in 7.5%. In the training set, Baveno VI, expanded Baveno VI, and HEPAVIR criteria spared 10.1%, 25.5%, and 28% of EGDs, while missing 0%, 1.2%, and 2.2% of EVNT, respectively. The best thresholds to rule out EVNT were platelets >110 000/μL and LSM <30 kPa (HIV cirrhosis criteria), with 34.6% of EGDs spared and 0% EVNT missed. In the validation set, HEPAVIR and HIV cirrhosis criteria spared 54% and 48.7% of EGDs, while missing 4.9% and 2.2% EVNT, respectively. [Conclusions] Baveno VI criteria can be extended to HEPAVIR and HIV cirrhosis criteria while sparing a significant number of EGDs, thus improving resource utilization for PLWH with compensated advanced chronic liver disease. | Descripción: | In Press. | Versión del editor: | https://doi.org/10.1093/cid/ciz1181 | URI: | http://hdl.handle.net/10261/212835 | DOI: | 10.1093/cid/ciz1181 | Identificadores: | doi: 10.1093/cid/ciz1181 e-issn: 1537-6591 issn: 1058-4838 |
Aparece en las colecciones: | (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
10
checked on 28-abr-2024
WEB OF SCIENCETM
Citations
10
checked on 25-feb-2024
Page view(s)
153
checked on 12-may-2024
Download(s)
19
checked on 12-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.